Karen S. Yee

2.1k total citations
30 papers, 1.5k citations indexed

About

Karen S. Yee is a scholar working on Molecular Biology, Physiology and Clinical Psychology. According to data from OpenAlex, Karen S. Yee has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Physiology and 9 papers in Clinical Psychology. Recurrent topics in Karen S. Yee's work include Lysosomal Storage Disorders Research (13 papers), Family and Disability Support Research (7 papers) and Glycogen Storage Diseases and Myoclonus (6 papers). Karen S. Yee is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Family and Disability Support Research (7 papers) and Glycogen Storage Diseases and Myoclonus (6 papers). Karen S. Yee collaborates with scholars based in United States, United Kingdom and Singapore. Karen S. Yee's co-authors include Karen H. Vousden, Victor C. Yu, Eric O’Neill, Simon Wilkinson, Kevin M. Ryan, Joanna L. James, David Matallanas, David Romano, Walter Kölch and Lucia Kučerová and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Cancer Research.

In The Last Decade

Karen S. Yee

28 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen S. Yee United States 14 1.1k 497 429 229 172 30 1.5k
Mahmut Yilmaz Switzerland 7 681 0.6× 237 0.5× 435 1.0× 233 1.0× 295 1.7× 7 1.3k
Pingzhao Zhang China 24 1.1k 0.9× 264 0.5× 274 0.6× 136 0.6× 357 2.1× 54 1.4k
Qinxi Li China 22 1.1k 0.9× 178 0.4× 287 0.7× 289 1.3× 314 1.8× 39 1.5k
Marion Bouchecareilh France 20 866 0.8× 954 1.9× 203 0.5× 566 2.5× 337 2.0× 40 1.7k
Diane Crighton United Kingdom 17 1.3k 1.2× 397 0.8× 581 1.4× 935 4.1× 355 2.1× 24 2.1k
Christine Naczki United States 8 756 0.7× 656 1.3× 146 0.3× 432 1.9× 335 1.9× 9 1.4k
Ashley Craig United Kingdom 17 794 0.7× 214 0.4× 477 1.1× 113 0.5× 179 1.0× 23 1.2k
Mari Nishino United States 8 1.3k 1.2× 316 0.6× 309 0.7× 285 1.2× 122 0.7× 12 1.7k
Taesaeng Choi South Korea 12 1.0k 0.9× 614 1.2× 486 1.1× 63 0.3× 127 0.7× 23 1.6k
Chul‐Woong Chung South Korea 12 829 0.7× 170 0.3× 306 0.7× 112 0.5× 112 0.7× 20 1.1k

Countries citing papers authored by Karen S. Yee

Since Specialization
Citations

This map shows the geographic impact of Karen S. Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen S. Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen S. Yee more than expected).

Fields of papers citing papers by Karen S. Yee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen S. Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen S. Yee. The network helps show where Karen S. Yee may publish in the future.

Co-authorship network of co-authors of Karen S. Yee

This figure shows the co-authorship network connecting the top 25 collaborators of Karen S. Yee. A scholar is included among the top collaborators of Karen S. Yee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen S. Yee. Karen S. Yee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muenzer, Joseph, Barbara K. Burton, Paul Harmatz, et al.. (2024). Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase‐ IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II. Journal of Inherited Metabolic Disease. 48(3). e12790–e12790. 1 indexed citations
3.
Evuarherhe, Obaro, et al.. (2024). A Systematic Literature Review on the Global Status of Newborn Screening for Mucopolysaccharidosis II. International Journal of Neonatal Screening. 10(4). 71–71. 1 indexed citations
5.
Yee, Karen S., et al.. (2023). Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II. Molecular Genetics and Metabolism. 140(3). 107652–107652. 1 indexed citations
6.
Muenzer, Joseph, Barbara K. Burton, Paul Harmatz, et al.. (2022). Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study. Molecular Genetics and Metabolism. 137(1-2). 127–139. 23 indexed citations
7.
Muenzer, Joseph, Barbara K. Burton, Paul Harmatz, et al.. (2022). Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II. Molecular Genetics and Metabolism. 137(1-2). 92–103. 8 indexed citations
8.
Yee, Karen S., et al.. (2021). Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II. Orphanet Journal of Rare Diseases. 16(1). 501–501. 7 indexed citations
9.
Yee, Karen S., Daniel Serrano, Judith C. Kando, & Susan L. McElroy. (2019). A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder. Quality of Life Research. 28(12). 3385–3394. 6 indexed citations
10.
Yee, Karen S., Lukasz F. Grochola, Garth Hamilton, et al.. (2012). A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma. Cancer Research. 72(9). 2206–2217. 32 indexed citations
11.
Yee, Karen S. & Eric O’Neill. (2010). YAP1—Friend AND foe. Cell Cycle. 9(8). 1447–1448. 7 indexed citations
12.
Yee, Karen S., Simon Wilkinson, Joanna L. James, Kevin M. Ryan, & Karen H. Vousden. (2009). PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death and Differentiation. 16(8). 1135–1145. 205 indexed citations
13.
Hamilton, Garth, Karen S. Yee, Simon Scrace, & Eric O’Neill. (2009). ATM Regulates a RASSF1A-Dependent DNA Damage Response. Current Biology. 19(23). 2020–2025. 86 indexed citations
14.
Yee, Karen S. & Karen H. Vousden. (2007). Contribution of membrane localization to the apoptotic activity of PUMA. APOPTOSIS. 13(1). 87–95. 40 indexed citations
15.
Matallanas, David, David Romano, Karen S. Yee, et al.. (2007). RASSF1A Elicits Apoptosis through an MST2 Pathway Directing Proapoptotic Transcription by the p73 Tumor Suppressor Protein. Molecular Cell. 27(6). 962–975. 331 indexed citations
16.
Yee, Karen S. & Karen H. Vousden. (2005). Complicating the complexity of p53. Carcinogenesis. 26(8). 1317–1322. 150 indexed citations
17.
Melino, Gerry, Francesca Bernassola, Marco Ranalli, et al.. (2004). p73 Induces Apoptosis via PUMA Transactivation and Bax Mitochondrial Translocation. Journal of Biological Chemistry. 279(9). 8076–8083. 299 indexed citations
18.
Tan, Kuan Onn, et al.. (2001). MAP-1, a Novel Proapoptotic Protein Containing a BH3-like Motif That Associates with Bax through Its Bcl-2 Homology Domains. Journal of Biological Chemistry. 276(4). 2802–2807. 116 indexed citations
19.
Chan, Shing Leng, Karen S. Yee, Karen Tan, & Victor C. Yu. (2000). The Caenorhabditis elegans Sex Determination Protein FEM-1 Is a CED-3 Substrate That Associates with CED-4 and Mediates Apoptosis in Mammalian Cells. Journal of Biological Chemistry. 275(24). 17925–17928. 25 indexed citations
20.
Yee, Karen S. & Victor C. Yu. (1998). Isolation and Characterization of a Novel Member of the Neural Zinc Finger Factor/Myelin Transcription Factor Family with Transcriptional Repression Activity. Journal of Biological Chemistry. 273(9). 5366–5374. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026